Results 231 to 240 of about 1,873,134 (303)

Doxorubicin‐induced Cardiotoxicity in Dogs: A Narrative Review

Veterinary and Comparative Oncology, EarlyView.
ABSTRACT Doxorubicin, an anthracycline widely used in both human and veterinary oncology, is highly effective against a variety of malignancies in dogs, including lymphomas, sarcomas and carcinomas. Despite its efficacy, doxorubicin exposure can be associated with cardiotoxicity, which may present acutely or chronically, potentially leading to severe ...
Supita Sunpongsri, Tom Roos, Ronette Gerhing, Maurice Zandvliet, Giorgia Santarelli   +4 more
wiley   +1 more source

Benign mixed mammary tumor with sebaceous differentiation in a dog. [PDF]

J Vet Med Sci
Ma Y, Shi J, Lu H, Zhang J, Liu Z, Wei J, Zhao K, Gao F, He W.   +8 more
europepmc   +1 more source

Laparoscopic‐assisted treatment of giant urachal cyst in a female Dachshund

Veterinary Surgery, EarlyView.
Abstract Objective To describe the clinical features and successful surgical management of a giant, symptomatic urachal cyst (UC) in a dog using a laparoscopic‐assisted approach without partial cystectomy. Study design Case report. Animal A 10‐year‐old, 4.6 kg, spayed female Dachshund.
Jiyoung Park, Won‐Jong Lee, Jaemin Jeong, Haebeom Lee, Seong Mok Jeong, Dae‐Hyun Kim   +5 more
wiley   +1 more source

Severe degranulation of mesenteric mast cells in an experimental rat mammary tumor model. [PDF]

Turk J Med Sci
Yavaş SE, Yavaş Ö, Ersoy S, Sönmez G.   +3 more
europepmc   +1 more source

Muscle wasting in cancer cachexia: Mechanisms and the role of exercise

Experimental Physiology, EarlyView.
Abstract Cancer cachexia (CC) is a multifactorial disease marked by a severe and progressive loss of lean muscle mass and characterized further by inflammation and a negative energy/protein balance, ultimately leading to muscle atrophy and loss of muscle tissue.
Zoe P. Libramento, Louisa Tichy, Traci L. Parry   +2 more
wiley   +1 more source

A novel thrombospondin-1 variant as a potential diagnostic biomarker and therapeutic target in canine mammary tumor and osteosarcoma cells. [PDF]

J Vet Sci
Hong Y, Baik H, Lee J, Oh WS, Ryu J, Baek SJ.   +5 more
europepmc   +1 more source

Maternal obesity during lactation as a hypertensive cardiovascular risk factor in the offspring

Experimental Physiology, EarlyView.
Abstract Maternal obesity is a major public health concern, with growing evidence supporting its role in the developmental programming of cardiometabolic disease. Although prenatal mechanisms have been investigated extensively, the contribution of lactation as a postnatal window of cardiovascular (CV) programming remains insufficiently understood ...
Gabriela Arenas, Cristián A. Amador, Susana Contreras‐Duarte   +2 more
wiley   +1 more source

Understanding and reversing mammary tumor-driven reprogramming of myelopoiesis to reduce metastatic spread.

Cancer Cell
Garner H, Martinovic M, Liu NQ, Bakker NAM, Velilla IQ, Hau CS, Vrijland K, Kaldenbach D, Kok M, de Wit E, de Visser KE.   +10 more
europepmc   +1 more source

Docetaxel response in BRCA1,p53-deficient mammary tumor cells is affected by Huntingtin and BAP1. [PDF]

Proc Natl Acad Sci U S A
González-Fernández M, Perry C, Gerhards NM, Francica P, Rottenberg S.   +4 more
europepmc   +1 more source